Sulfasalazine or Salazopyrin is indicated for the treatment of active Rheumatoid Arthritis and some other inflammatory arthropathies. It is normally used together with Non Steroidal Anti-inflammatory Drugs particularly in the early stages of treatment. Response to treatment cannot be expected before three months and may not occur until after six months of treatment.
CONTRA-INDICATIONS
- Pregnancy and lactation
- Gross renal, lung, bowel or hepatic disease
- Blood dyscrasias
- Known hypersensitivity to sulphonamides
- Reversible male sub-fertility
DOSAGE
- Starting Dose 500mg daily
- Dose Increments 500mg weekly until dose of 1g twice a day.
- If inadequate response dose can be increased to 3g daily in divided doses.
- Total duration of treatment - as long as indicated by clinical condition.
- Use enteric coated preparation.
MONITORING
- Pre-treatment screening
- monitoring every 4 weeks for 3 months
- then every 3 months.
| PRE TREATMENT SCREENING | EACH MONITORING VISIT |
|---|---|
|
|
ADVERSE EVENTS
| LABORATORY EVENTS | VALUES | ACTION |
|---|---|---|
| Leucopaenia | < 3.5 x 10 9 /l | STOP + seek advice |
| Neutropaenia | < 2.5 x 10 9 /l | STOP + seek advice |
| Thrombocytopaenia | < 150 x 10 9 /l | STOP + seek advice |
| Macrocytosis | > 100 | Check B12 and folate |
| Sequential falls in WBC or neutrophils | > 10% on 3 occasions | STOP + seek advice |
| Sequential falls in Platelets | > 10% on 3 occasions | STOP unless falls are from high level e.g. 600, 500, 400 x 10 3 which are response to treatment |
| Elevation of liver enzymes (AST, ALT) | > 3x normal |
|
| CLINICAL ADVERSE EVENTS | MANAGEMENT |
|---|---|
| Rash |
Often non-specific erythematous, dry and itchy.
|
| Mouth Ulcers/Stomatitis |
|
| Fever/Flu like illness |
|
| Nausea |
|
| Urine discolouration | Reassure |
| Discolouration of soft contact lenses | Warn patient |
Source: Dr PR Crook, Consultant Rheumatologist.